issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would
by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged
or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In
year, the Company has not yet earned income from Excellence Center (New Building) planned to official grand opening in the following year of February 2018) along with the enlarged customer base of the
conditions applied for extended payment term in which 2nd – 7th installment starts in year 5 to year 10: To provide network based on IMT- 2020 (5G) technology of at least 50% geographical coverage of the
period of loan, from the previous on 24/02/2018 1st extended : Extended for 3 months, the remaining loan amount of 115.8 million baht, interest rate amount of 1.74 million baht 2nd extended : Extended for
remaining share will be determined to the existing shareholder who subscribed and paid up by its allotment and be able to over-subscribe to its allotment. WCIH determined the date to subscribed and paid up
decoration, service fee for specialist and interest expense, while the remaining THB 548 million accounts for land acquisition and construction of staff house for employees of Phuket Fantasea Company Limited
Tel. 02-897-8888, 02-897-8800 Fax. 02-897-8890 1. * The company required to extend the period of loan, from the previous on 24/02/2018 1st extended : Extended for 3 months, the remaining loan amount of